|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print October 24, 2001
Am J Physiol Gastrointest Liver Physiol, 10.1152/ajpgi.00304.2001
Submitted on July 9, 2001
Accepted on October 17, 2001
1 Department of Medicine and Marion Bessin Liver Research Center, Albert Einstein College of Medicine, Bronx, NY, USA
2 Departments of Medicine and Biochemistry and Biophysics, University of North Carolina, Chapel Hill, NC, USA
* To whom correspondence should be addressed. E-mail: CZAJA{at}AECOM.YU.EDU, caponigr@aecom.yu.edu.
The mechanisms that underlie hepatocyte sensitization to TNF-
-mediated cell death remain unclear. Increases in hepatocellular oxidant stress such as occur with hepatic overexpression of cytochrome P450 2E1 (CYP2E1) may promote TNF-
death. TNF-
treatment of hepatocyte cell lines with differential CYP2E1 expression demonstrated that overexpression of CYP2E1 converted the hepatocyte TNF-
response from proliferation to apoptotic and necrotic cell death. Death occurred despite the presence of increased levels of NF-
B transcriptional activity, and was associated with increased lipid peroxidation and GSH depletion. CYP2E1-overexpressing hepatocytes had increased basal, and TNF-
-induced levels of c-Jun N-terminal kinase (JNK) activity, as well as a prolongation of JNK activation after TNF-
stimulation. Sensitization to TNF-
-induced cell death by CYP2E1 overexpression was inhibited by antioxidants or adenoviral expression of a dominant negative c-Jun. Increased CYP2E1 expression sensitized hepatocytes to TNF-
toxicity mediated by c-Jun and overwhelming oxidative stress. The chronic increase in intracellular oxidant stress created by CYP2E1 overexpression may serve as a mechanism by which hepatocytes are sensitized to TNF-
toxicity in liver disease.
This article has been cited by other articles:
![]() |
A. Perra, G. Simbula, M. Simbula, M. Pibiri, M. A. Kowalik, P. Sulas, M. T. Cocco, G. M. Ledda-Columbano, and A. Columbano Thyroid hormone (T3) and TR{beta} agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats FASEB J, August 1, 2008; 22(8): 2981 - 2989. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Perra, M. Pibiri, P. Sulas, G. Simbula, G. M. Ledda-Columbano, and A. Columbano {alpha}-lipoic acid promotes the growth of rat hepatic pre-neoplastic lesions in the choline-deficient model Carcinogenesis, January 1, 2008; 29(1): 161 - 168. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Kang, H. Wanibuchi, K. Morimura, F. J. Gonzalez, and S. Fukushima Role of CYP2E1 in Diethylnitrosamine-Induced Hepatocarcinogenesis In vivo Cancer Res., December 1, 2007; 67(23): 11141 - 11146. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Venugopal, J. Chen, Y. Zhang, D. Clemens, A. Follenzi, and M. A. Zern Role of MAPK Phosphatase-1 in Sustained Activation of JNK during Ethanol-induced Apoptosis in Hepatocyte-like VL-17A Cells J. Biol. Chem., November 2, 2007; 282(44): 31900 - 31908. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Cao, K. M. Mak, and C. S. Lieber Cytochrome P4502E1 primes macrophages to increase TNF-{alpha} production in response to lipopolysaccharide Am J Physiol Gastrointest Liver Physiol, July 1, 2005; 289(1): G95 - G107. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hilgard, M. J. Czaja, G. Gerken, and R. J. Stockert Proapoptotic function of protein kinase CK2{alpha}" is mediated by a JNK signaling cascade Am J Physiol Gastrointest Liver Physiol, July 1, 2004; 287(1): G192 - G201. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Czaja The Future of GI and Liver Research: Editorial Perspectives: III. JNK/AP-1 regulation of hepatocyte death Am J Physiol Gastrointest Liver Physiol, June 1, 2003; 284(6): G875 - G879. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |